table of content
1 Study Coverage
1.1 NSAIDs Product Introduction
1.2 Market by Type
1.2.1 Global NSAIDs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Aspirin
1.2.3 Ibuprofen
1.2.4 Naproxen
1.2.5 Nabumetone
1.2.6 Others
1.3 Market by Application
1.3.1 Global NSAIDs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Back Pain Treatment
1.3.3 Osteoarthritis Treatment
1.3.4 Other Disease Treatment
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global NSAIDs Sales Estimates and Forecasts 2017-2028
2.2 Global NSAIDs Revenue Estimates and Forecasts 2017-2028
2.3 Global NSAIDs Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global NSAIDs Sales by Region
2.4.1 Global NSAIDs Sales by Region (2017-2022)
2.4.2 Global Sales NSAIDs by Region (2023-2028)
2.5 Global NSAIDs Revenue by Region
2.5.1 Global NSAIDs Revenue by Region (2017-2022)
2.5.2 Global NSAIDs Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global NSAIDs Sales by Manufacturers
3.1.1 Global Top NSAIDs Manufacturers by Sales (2017-2022)
3.1.2 Global NSAIDs Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of NSAIDs in 2021
3.2 Global NSAIDs Revenue by Manufacturers
3.2.1 Global NSAIDs Revenue by Manufacturers (2017-2022)
3.2.2 Global NSAIDs Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by NSAIDs Revenue in 2021
3.3 Global NSAIDs Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global NSAIDs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global NSAIDs Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global NSAIDs Sales by Type
4.1.1 Global NSAIDs Historical Sales by Type (2017-2022)
4.1.2 Global NSAIDs Forecasted Sales by Type (2023-2028)
4.1.3 Global NSAIDs Sales Market Share by Type (2017-2028)
4.2 Global NSAIDs Revenue by Type
4.2.1 Global NSAIDs Historical Revenue by Type (2017-2022)
4.2.2 Global NSAIDs Forecasted Revenue by Type (2023-2028)
4.2.3 Global NSAIDs Revenue Market Share by Type (2017-2028)
4.3 Global NSAIDs Price by Type
4.3.1 Global NSAIDs Price by Type (2017-2022)
4.3.2 Global NSAIDs Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global NSAIDs Sales by Application
5.1.1 Global NSAIDs Historical Sales by Application (2017-2022)
5.1.2 Global NSAIDs Forecasted Sales by Application (2023-2028)
5.1.3 Global NSAIDs Sales Market Share by Application (2017-2028)
5.2 Global NSAIDs Revenue by Application
5.2.1 Global NSAIDs Historical Revenue by Application (2017-2022)
5.2.2 Global NSAIDs Forecasted Revenue by Application (2023-2028)
5.2.3 Global NSAIDs Revenue Market Share by Application (2017-2028)
5.3 Global NSAIDs Price by Application
5.3.1 Global NSAIDs Price by Application (2017-2022)
5.3.2 Global NSAIDs Price Forecast by Application (2023-2028)
6 North America
6.1 North America NSAIDs Market Size by Type
6.1.1 North America NSAIDs Sales by Type (2017-2028)
6.1.2 North America NSAIDs Revenue by Type (2017-2028)
6.2 North America NSAIDs Market Size by Application
6.2.1 North America NSAIDs Sales by Application (2017-2028)
6.2.2 North America NSAIDs Revenue by Application (2017-2028)
6.3 North America NSAIDs Market Size by Country
6.3.1 North America NSAIDs Sales by Country (2017-2028)
6.3.2 North America NSAIDs Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe NSAIDs Market Size by Type
7.1.1 Europe NSAIDs Sales by Type (2017-2028)
7.1.2 Europe NSAIDs Revenue by Type (2017-2028)
7.2 Europe NSAIDs Market Size by Application
7.2.1 Europe NSAIDs Sales by Application (2017-2028)
7.2.2 Europe NSAIDs Revenue by Application (2017-2028)
7.3 Europe NSAIDs Market Size by Country
7.3.1 Europe NSAIDs Sales by Country (2017-2028)
7.3.2 Europe NSAIDs Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific NSAIDs Market Size by Type
8.1.1 Asia Pacific NSAIDs Sales by Type (2017-2028)
8.1.2 Asia Pacific NSAIDs Revenue by Type (2017-2028)
8.2 Asia Pacific NSAIDs Market Size by Application
8.2.1 Asia Pacific NSAIDs Sales by Application (2017-2028)
8.2.2 Asia Pacific NSAIDs Revenue by Application (2017-2028)
8.3 Asia Pacific NSAIDs Market Size by Region
8.3.1 Asia Pacific NSAIDs Sales by Region (2017-2028)
8.3.2 Asia Pacific NSAIDs Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America NSAIDs Market Size by Type
9.1.1 Latin America NSAIDs Sales by Type (2017-2028)
9.1.2 Latin America NSAIDs Revenue by Type (2017-2028)
9.2 Latin America NSAIDs Market Size by Application
9.2.1 Latin America NSAIDs Sales by Application (2017-2028)
9.2.2 Latin America NSAIDs Revenue by Application (2017-2028)
9.3 Latin America NSAIDs Market Size by Country
9.3.1 Latin America NSAIDs Sales by Country (2017-2028)
9.3.2 Latin America NSAIDs Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa NSAIDs Market Size by Type
10.1.1 Middle East and Africa NSAIDs Sales by Type (2017-2028)
10.1.2 Middle East and Africa NSAIDs Revenue by Type (2017-2028)
10.2 Middle East and Africa NSAIDs Market Size by Application
10.2.1 Middle East and Africa NSAIDs Sales by Application (2017-2028)
10.2.2 Middle East and Africa NSAIDs Revenue by Application (2017-2028)
10.3 Middle East and Africa NSAIDs Market Size by Country
10.3.1 Middle East and Africa NSAIDs Sales by Country (2017-2028)
10.3.2 Middle East and Africa NSAIDs Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Overview
11.1.3 Bayer NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bayer NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bayer Recent Developments
11.2 Novacap
11.2.1 Novacap Corporation Information
11.2.2 Novacap Overview
11.2.3 Novacap NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Novacap NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Novacap Recent Developments
11.3 Abbott
11.3.1 Abbott Corporation Information
11.3.2 Abbott Overview
11.3.3 Abbott NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abbott NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abbott Recent Developments
11.4 Pfizer
11.4.1 Pfizer Corporation Information
11.4.2 Pfizer Overview
11.4.3 Pfizer NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Pfizer NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Pfizer Recent Developments
11.5 Johnson & Johnson
11.5.1 Johnson & Johnson Corporation Information
11.5.2 Johnson & Johnson Overview
11.5.3 Johnson & Johnson NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Johnson & Johnson NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Johnson & Johnson Recent Developments
11.6 Cigna
11.6.1 Cigna Corporation Information
11.6.2 Cigna Overview
11.6.3 Cigna NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Cigna NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Cigna Recent Developments
11.7 Geri-Care Pharmaceuticals
11.7.1 Geri-Care Pharmaceuticals Corporation Information
11.7.2 Geri-Care Pharmaceuticals Overview
11.7.3 Geri-Care Pharmaceuticals NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Geri-Care Pharmaceuticals NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Geri-Care Pharmaceuticals Recent Developments
11.8 Perrigo Company
11.8.1 Perrigo Company Corporation Information
11.8.2 Perrigo Company Overview
11.8.3 Perrigo Company NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Perrigo Company NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Perrigo Company Recent Developments
11.9 Kopran
11.9.1 Kopran Corporation Information
11.9.2 Kopran Overview
11.9.3 Kopran NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Kopran NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Kopran Recent Developments
11.10 Merck Sharp & Dohme
11.10.1 Merck Sharp & Dohme Corporation Information
11.10.2 Merck Sharp & Dohme Overview
11.10.3 Merck Sharp & Dohme NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Merck Sharp & Dohme NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Merck Sharp & Dohme Recent Developments
11.11 Sun Pharmaceutical Industries
11.11.1 Sun Pharmaceutical Industries Corporation Information
11.11.2 Sun Pharmaceutical Industries Overview
11.11.3 Sun Pharmaceutical Industries NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Sun Pharmaceutical Industries NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Sun Pharmaceutical Industries Recent Developments
11.12 GlaxoSmithKline
11.12.1 GlaxoSmithKline Corporation Information
11.12.2 GlaxoSmithKline Overview
11.12.3 GlaxoSmithKline NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 GlaxoSmithKline NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 GlaxoSmithKline Recent Developments
11.13 Reddy Pharmaceuticals
11.13.1 Reddy Pharmaceuticals Corporation Information
11.13.2 Reddy Pharmaceuticals Overview
11.13.3 Reddy Pharmaceuticals NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Reddy Pharmaceuticals NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Reddy Pharmaceuticals Recent Developments
11.14 Verywell
11.14.1 Verywell Corporation Information
11.14.2 Verywell Overview
11.14.3 Verywell NSAIDs Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Verywell NSAIDs Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Verywell Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 NSAIDs Industry Chain Analysis
12.2 NSAIDs Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 NSAIDs Production Mode & Process
12.4 NSAIDs Sales and Marketing
12.4.1 NSAIDs Sales Channels
12.4.2 NSAIDs Distributors
12.5 NSAIDs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 NSAIDs Industry Trends
13.2 NSAIDs Market Drivers
13.3 NSAIDs Market Challenges
13.4 NSAIDs Market Restraints
14 Key Findings in The Global NSAIDs Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer